Lipiodol
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Overview
|
WikiDoc Resources for Lipiodol | |
|
Articles | |
|---|---|
|
Most recent articles on Lipiodol | |
|
Media | |
|
Evidence Based Medicine | |
|
Clinical Trials | |
|
Ongoing Trials on Lipiodol at Clinical Trials.gov Clinical Trials on Lipiodol at Google
| |
|
Guidelines / Policies / Govt | |
|
US National Guidelines Clearinghouse on Lipiodol
| |
|
Books | |
|
News | |
|
Commentary | |
|
Definitions | |
|
Patient Resources / Community | |
|
Directions to Hospitals Treating Lipiodol Risk calculators and risk factors for Lipiodol
| |
|
Healthcare Provider Resources | |
|
Causes & Risk Factors for Lipiodol | |
|
Continuing Medical Education (CME) | |
|
International | |
|
| |
|
Businness | |
|
Experimental / Informatics | |
Lipiodol is an iodinated, radio-opaque contrast material that is used to outline structures in radiological investigations.
It is used in chemoembolization applications as a contrast agent in follow-up imaging. It has an additional use in gastric variceal obliteration as a dilutant that does not affect polymerization of cyanoacrylate.
Lipiodol is also used in lymphangiography, the imaging of the lymphatic system.
Historically it was often used as a contrast media at hysterosalpingography(HSG). This is an investigation to determine tubal patency as part of the investigation of subfertility. It became less commonly utilised in the 1960s to 1980s because the more modern water soluble media give images that are easier to interpret. There is also an important safety issue with lipiodol in that intravasation (leakage) of the fluid into the venous system has caused patients to be uwell in the past because of intravasation.
Recently there has been an increasing interest in the use of lipiodol as a therapeutic agent in the management of unexplained infertility called lipiodol flushing. There have been a small number of studies that suggest that flushing the media through the tubes gives a short term rise in fecundity in patients with unexplained infertility. A recent systematic review has suggested a significant increase in fertility, especially in those women who have endometriosis when using lipiodol flushing (Johnson N.P et al).
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .
